AU7632198A - Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof - Google Patents
Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereofInfo
- Publication number
- AU7632198A AU7632198A AU76321/98A AU7632198A AU7632198A AU 7632198 A AU7632198 A AU 7632198A AU 76321/98 A AU76321/98 A AU 76321/98A AU 7632198 A AU7632198 A AU 7632198A AU 7632198 A AU7632198 A AU 7632198A
- Authority
- AU
- Australia
- Prior art keywords
- paclitaxel
- ready
- preparing
- pharmaceutical form
- administering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9700515 | 1997-06-13 | ||
BE9700515A BE1011216A3 (fr) | 1997-06-13 | 1997-06-13 | Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition. |
PCT/BE1998/000078 WO1998057630A1 (fr) | 1997-06-13 | 1998-06-02 | Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7632198A true AU7632198A (en) | 1999-01-04 |
Family
ID=3890575
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU76321/98A Abandoned AU7632198A (en) | 1997-06-13 | 1998-06-02 | Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR012972A1 (fr) |
AU (1) | AU7632198A (fr) |
BE (1) | BE1011216A3 (fr) |
WO (1) | WO1998057630A1 (fr) |
ZA (1) | ZA984832B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6964946B1 (en) | 1995-10-26 | 2005-11-15 | Baker Norton Pharmaceuticals, Inc. | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
DE60136648D1 (de) | 2000-12-05 | 2009-01-02 | Los Angeles Childrens Hospital | Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung |
EP1498143A1 (fr) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Formulations auto-émulsifiantes et auto-microémulsifiantes pour l'administration orale de taxoides |
WO2005017079A1 (fr) * | 2003-07-24 | 2005-02-24 | Dabur Research Foundation | Procede de purification de solvants non ioniques pour preparations pharmaceutiques injectables stabilisees |
US20050016926A1 (en) | 2003-07-24 | 2005-01-27 | Dabur Research Foundation | Stabilized formulation |
CN1853728A (zh) * | 2005-04-19 | 2006-11-01 | 上海天博生物科技有限公司 | 一种改善药物或营养物口服吸收的方法、配方及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US4960790A (en) * | 1989-03-09 | 1990-10-02 | University Of Kansas | Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof |
FR2678833B1 (fr) * | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
ATE169216T1 (de) * | 1992-11-27 | 1998-08-15 | Napro Biotherapeutics Inc | Paclitaxel enthaltende injizierbare zusammensetzung |
NZ258044A (en) * | 1992-11-27 | 1995-12-21 | Faulding F H & Co Ltd | Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
TW406020B (en) * | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
US5681846A (en) * | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
-
1997
- 1997-06-13 BE BE9700515A patent/BE1011216A3/fr not_active IP Right Cessation
-
1998
- 1998-06-02 WO PCT/BE1998/000078 patent/WO1998057630A1/fr active Application Filing
- 1998-06-02 AU AU76321/98A patent/AU7632198A/en not_active Abandoned
- 1998-06-04 ZA ZA984832A patent/ZA984832B/xx unknown
- 1998-06-11 AR ARP980102786A patent/AR012972A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
BE1011216A3 (fr) | 1999-06-01 |
ZA984832B (en) | 1999-01-04 |
WO1998057630A1 (fr) | 1998-12-23 |
AR012972A1 (es) | 2000-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145983A0 (en) | Pharmaceutical composition for dermal use, comprising a corticosteroid and a vitamin d or an analogue thereof | |
ZA962536B (en) | Pharmaceutical composition for transdermal administration. | |
PL354322A1 (en) | 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds | |
ZA200000842B (en) | Method and system for administering a medication. | |
HUP0004050A3 (en) | Itraconazole exhibiting improved solubility, a method of preparing the same and pharmaceutical composition for oral administration comprising the same | |
HUP0004024A3 (en) | Azabenzimidazole-based compounds, process for their preparation and pharmaceutical composition thereof | |
IL147220A0 (en) | Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same | |
IL135920A0 (en) | 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor | |
HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
AU7640696A (en) | Thiazolidinedione derivatives, method for preparing the derivatives and pharmaceutical compositions containing same | |
HUP0001494A3 (en) | 3-phenoxy-, 3-dibenzo[a,d]cycloheptenyloxy-, 3-dibenz[b,f][1,4]oxazepinyloxy-1-amino-2-propanol derivatives and pharmaceutical compositions containing them | |
ZA200007299B (en) | Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol. | |
HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
HUP0002843A3 (en) | New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them | |
AU1689999A (en) | Medicinal composition for percutaneous administration | |
AU7534794A (en) | A method and pharmaceutical compositions for drug targeting | |
AU2345695A (en) | Pharmaceutical composition for transdermal delivery | |
HUP0001551A3 (en) | Improved method for producing thiazolidinediones, thiazolidinediones and pharmaceutical compositions containing the same | |
AU7632198A (en) | Pharmaceutical form for administering paclitaxel, method for preparing a ready-for-use paclitaxel composition and thereof | |
AU3825700A (en) | Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines | |
AU8031598A (en) | 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them | |
AU3055099A (en) | A pharmaceutical formulation for nasal administration | |
AU5406099A (en) | A pharmaceutical composition containing calcineurin b subunit | |
AU7655694A (en) | A method and pharmaceutical and diagnosis compositions for drug targeting | |
AU3393600A (en) | Method for safely and effectively administering a drug by inhalation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |